Dual functional selenium-substituted hydroxyapatite

Interface Focus

Volumn 2, Issue 3, 2012, Pages 378-386

  Wang, Yanhua ^a   Ma, Jun ^a   Zhou, Lei ^a   Chen, Jin ^a   Liu, Yonghui ^a   Qiu, Zhiye ^a   Zhang, Shengmin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bone repair; Hydroxyapatite; Malignant bone tumour; Nanoparticles; Selenium

Indexed keywords

EID: 84860851296     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2012.0002     Document Type: Article

References (48)

1. Rensberger, J. M. & Watabe, M. 2000 Fine structure of bone in dinosaurs, birds and mammals. Nature 406,619-622. (doi:10.1038/35020550)
2. Montufar-Solis, D., Nguyen, H. C., Nguyen, H. D., Horn, W. N., Cody, D. D. & Duke, P. J. 2004 Using cartilage to repair bone: an alternative approach in tissue engineering. Ann. Biomed. Eng. 32, 504-509. (doi:10.1023/B:ABME.0000017546.29064.fc)
3. Allori, A. C., Sailon, A. M. & Warren, S. M. 2008 Biological basis of bone formation, remodeling, and repair-part. I. Biochemical signaling molecules. Tissue Eng. Part B Rev. 14, 259-273. (doi:10.1089/ten.teb.2008.0082)
4. Elliott, J. C. 1994 Structure and chemistry of the apatites and other calcium orthophosphates. Amsterdam, The Netherlands: Elsevier.
5. Laurencin, D. et al. 2011 Magnesium incorporation into hydroxyapatite. Biomaterials 32, 1826-1837. (doi:10.1016/j.biomaterials.2010.11.017)
6. Patel, N., Best, S. M., Bonfield, W., Gibson, I. R., Hing, K. A., Damien, E. & Revell, P. A. 2002 A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J. Mater. Sci. Mater. Med. 13, 1199-1206. (doi:10.1023/A:1021114710076)
7. Gomes, S., Renaudin, G., Mesbah, A., Jallot, E., Bonhomme, C.,Babonneau,F.& Nedelec.,J. M. 2010 Thorough analysis of silicon substitution in biphasic calcium phosphate bioceramics: a multi-technique study. Acta Biomater. 6, 3264-3274. (doi:10.1016/j.actbio.2010.02.034)
8. Milachowski, K., Moschinski, D., Jaeschock, R. & Kaschner, A. 1980 The influence of zinc on bone healing in rats. Arch. Orthop. Trauma Surg. 96, 17-21. (doi:10.1007/BF01246137)
9. Ren, F., Xin, R., Ge, X. & Leng, Y. 2009 Characterization and structural analysis of zinc-substituted hydroxyapatites. Acta Biomater. 5, 3141-3149. (doi:10.1016/j.actbio.2009.04.014)
10. Koutsopoulos, S. 2002 Synthesis and characterization of hydroxyapatite crystals: a review study on the analytical methods. J. Biomed. Mater. Res. 62, 600-612. (doi:10.1002/jbm.10280)
11. de Lima, I. R., Alves, G. G., Soriano, C. A., Campaneli, A. P., Gasparoto, T. H., Ramos Jr, E. S., de Sena, L. A., Rossi, A. M. & Granjeiro, J. M. 2011 Understanding the impact of divalent cation substitution on hydroxyapatite: an in vitro multiparametric study on biocompatibility. J. Biomed. Mater. Res. A 98A, 351-358. (doi:10.1002/jbm.a.33126)
12. Lim, P. N., Tay, B. Y., Chan, C. M. & Thian, E. S. 2012 Synthesis and characterization of silver/silicon-cosubstituted nanohydroxyapatite. J. Biomed. Mater. Res. B Appl. Biomater. 100B, 285-291. (doi:10.1002/jbm.b.31951)
13. Balamurugan, A., Rebelo, A. H., Lemos, A. F., Rocha, J. H., Ventura, J. M. & Ferreira, J. M. 2008 Suitability evaluation of sol-gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response. Dent. Mater. 24, 1374-1380. (doi:10.1016/j.dental.2008.02.017)
14. Veiseh, O., Gunn, J. W., Kievit, F. M., Sun, C., Fang, C., Lee, J. S. & Zhang, M. 2009 Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 5, 256-264. (doi:10.1002/smll.200800646)
15. Hou, C. H., Hou, S. M., Hsueh, Y. S., Lin, J., Wu, H. C. & Lin, F. H. 2009 The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy. Biomaterials 30, 3956-3960. (doi:10.1016/j.biomaterials.2009.04.020)
16. Andronescu, E., Ficai, M., Voicu, G., Ficai, D., Maganu, M. & Ficai, A. 2010 Synthesis and characterization of collagen/ hydroxyapatite: magnetite composite material for bone cancer treatment. J. Mater. Sci. Mater. Med. 21, 2237-2242. (doi:10.1007/s10856-010-4076-7)
17. Yuan, Y., Liu, C., Qian, J., Wang, J. & Zhang, Y. 2010 Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials 31, 730-740. (doi:10.1016/j.biomaterials.2009.09.088)
18. Chen, X., Deng, C., Tang, S. & Zhang, M. 2007 Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biol. Pharm. Bull. 30, 128-132. (doi:10.1248/bpb.30.128)
19. Theiszova, M., Jantova, S., Letasiova, S., Palou, M. & Cipak, L. 2008 Cytotoxicity of hydroxyapatite,fluorapatite and fluor-hydroxyapatite: a comparative in vitro study. Neoplasma 55, 312-316.
20. Shi, Z., Huang, X., Liu, B., Tao, H., Cai, Y. & Tang, R. 2010 Biological response of osteosarcoma cells to sizecontrolled nanostructured hydroxyapatite. J. Biomater. Appl. 25, 19-37. (doi:10.1177/0885328209339396)
21. Yoshida, Y., Osaka, S. & Tokuhashi, Y. 2009 Clinical experience of novel interconnected porous hydroxyapatite ceramics for the revision of tumor prosthesis: a case report. World J. Surg. Oncol. 7, 76. (doi:10.1186/1477-7819-7-76)
22. Meyers, P. A. et al. 2011 Addition of pamidronate to chemotherapy for the treatment of osteosarcoma. Cancer 117, 1736-1744. (doi:10.1002/cncr.25744)
23. Letavayova, L., Vlckova, V. & Brozmanova, J. 2006 Selenium: from cancer prevention to DNA damage. Toxicology 227, 1-14. (doi:10.1016/j.tox.2006.07.017)
24. Guan, L., Han, B., Li, Z., Hua, F., Huang, F., Wei, W., Yang, Y. & Xu, C. 2009 Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells. Apoptosis 14, 218-225. (doi:10.1007/s10495-008-0295-5)
25. Jackson, M. I. & Combs Jr, G. F. 2008 Selenium and anticarcinogenesis: underlying mechanisms. Curr. Opin. Clin. Nutr. Metab. Care 11, 718-726. (doi:10.1097/MCO.0b013e3283139674)
26. Zhou, J., Cheng, G., Tang, H. F. & Zhang, X. 2011 Novaeguinoside II inhibits cell proliferation and induces apoptosis of human brain glioblastoma U87MG cells through the mitochondrial pathway. Brain Res. 1372, 22-28. (doi:10.1016/j.brainres.2010.11.093)
27. Monteil-Rivera, F., Fedoroff, M., Jeanjean, J., Minel, L., Barthes, M. G. & Dumonceau, J. 2000 Sorption of selenite (SeO(3)(2-)) on hydroxyapatite: an exchange process. J. Colloid Interface Sci. 221, 291-300. (doi:10.1006/jcis.1999.6566)
28. Gillespie, P., Wu, G., Sayer, M. & Stott, M. J. 2010 Si complexes in calcium phosphate biomaterials. J. Mater. Sci. Mater. Med. 21, 99-108. (doi:10.1007/s10856-009-3852-8)
29. Darzynkiewicz, Z., Staiano-Coico, L. & Melamed, M. R. 1981 Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation. Proc. Natl Acad. Sci. USA 78, 2383-2387. (doi:10.1073/pnas.78.4.2383)
30. Gallo, D., Jacquot, Y., Laurent, G. & Leclercq, G. 2008 Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cells. Mol. Cell Endocrinol. 291, 20-26. (doi:10.1016/j.mce.2008.04.011)
31. Leong, K. W. & Adler, A. F. 2010 Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. Nano Today 5, 553-569. (doi:10.1016/j.nantod.2010.10.007)
32. 2+ substituted calcium phosphate nano particles synthesis for non viral gene delivery application. J. Mater. Sci. Mater. Med. 21, 2393-2401. (doi:10.1007/s10856-010-4088-3)
33. Vandiver, J., Dean, D., Patel, N., Bonfield, W. & Ortiz, C. 2005 Nanoscale variation in surface charge of synthetic hydroxyapatite detected by chemically and spatially specific high-resolution force spectroscopy. Biomaterials 26, 271-283. (doi:10.1016/j.biomaterials.2004.02.053)
34. Hildeman, D. A., Mitchell, T., Teague, T. K., Henson, P., Day, B. J., Kappler, J. & Marrack, P. C. 1999 Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744. (doi:10.1016/S1074-7613(00)80072-2)
35. Perlot Jr, R. L., Shapiro, I. M., Mansfield, K. & Adams, C. S. 2002 Matrix regulation of skeletal cell apoptosis. II. Role of Arg-Gly-Asp-containing peptides. J Bone Miner Res 17, 66-76. (doi:10.1359/jbmr.2002.17.1.66)
36. Saunders, R., Szymczyk, K. H., Shapiro, I. M. & Adams, C. S. 2007 Matrix regulation of skeletal cell apoptosis. III. Mechanism of ion pair-induced apoptosis. J. Cell Biochem. 100, 703-715. (doi:10.1002/jcb.21001)
37. Jung, U., Zheng, X., Yoon, S. O. & Chung, A. S. 2001 Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free Radic. Biol. Med. 31, 479-489. (doi:10.1016/S0891-5849(01)00604-9)
38. Abdulah, R., Miyazaki, K., Nakazawa, M. & Koyama, H. 2005 Chemical forms of selenium for cancer prevention. J. Trace Elem. Med. Biol. 19, 141-150. (doi:10.1016/j.jtemb.2005.09.003)
39. Lu, F., Wu, S. H., Hung, Y. & Mou, C. Y. 2009 Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5, 1408-1413. (doi:10.1002/smll.200900005)
40. Campayo, L., Grandjean, A., Coulon, A., Delorme, R., Vantelon, D. & Laurencin, D. 2011 Incorporation of iodates into hydroxyapatites: a new approach for the confinement of radioactive iodine. J. Mater. Chem. 21, 17609-17611. (doi:10.1039/C1JM14157K)
41. Lavastre, V., Roberge, C. J., Pelletier, M., Gauthier, M. & Girard, D. 2002 Toxaphene, but not beryllium, induces human neutrophil chemotaxis and apoptosis via reactive oxygen species (ROS): involvement of caspases and ROS in the degradation of cytoskeletal proteins. Clin. Immunol. 104, 40-48. (doi:10.1006/clim.2002.5226)
42. Fadeel, B., Ahlin, A., Henter, J. I., Orrenius, S. & Hampton, M. B. 1998 Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 92, 4808-4818.
43. Kim, A., Oh, J. H., Park, J. M.& Chung, A. S. 2007 Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspasemediated apoptosis of B16F10 melanoma cells. J. Cell Physiol. 212, 386-400. (doi:10.1002/jcp.21038)
44. Chen, T. & Wong, Y. S. 2009 Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells. Biomed. Pharmacother. 63, 105-113. (doi:10.1016/j.biopha.2008.03.009)
45. Nordberg, J. & Arner, E. S. 2001 Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31, 1287-1312. (doi:10.1016/S0891-5849(01)00724-9)
46. Diaz, B. et al. 2008 Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4, 2025-2034. (doi:10.1002/smll.200800199)
47. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P. & Wang, X. 1997 Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132. (doi:10.1126/science.275.5303.1129)
48. Torcia, M. et al. 2001 Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J. Biol. Chem. 276, 39027-39036.